By continuing to browse our site you agree to our Privacy Statement
arrow
Home
Aker BioMarine’s new venture...

Aker BioMarine’s new venture to advance Lysoveta for brain and eye pharmaceuticals

11 Jan 2021
-
Aa
+
trans